When anterior uveitis occurs in the context of juvenile idiopathic arthritis (JIA)–associated iridocyclitis or Behçet’s disease, the clinical picture differs from typical acute anterior uveitis and calls for a distinct, systemic approach.
This protocol applies to patients with anterior uveitis whose presentation is associated with juvenile idiopathic arthritis–associated iridocyclitis or Behçet’s disease. These conditions represent specific cases where standard short-course management alone is typically not appropriate.
Systemic immunosuppressive therapy, initiated in close coordination with an internist, is a key component of management in these cases. The choice of agent and the full treatment algorithm are specified in the complete protocol.
Complete agent selection, sequencing, and clinical decision algorithm available below.
DOI: 10.4103/0301-4738.58468
They are usually not used in acute anterior uveitis except in a few cases like JIA-associated iridocyclitis and Behcet's disease.
The immunosuppressives commonly used are methotrexate or azathioprine.
One needs to start immunosuppressive in conjunction with the internist.
View source ↗